57.
[]. Chang E, et al. Ezetimibe improves hepatic steatosis in relation to autophagy in obese and diabetic rats. World J Gastroenterol. 205 Jul 7;2(25):7754-.
[2]. Lee DH, et al. Ezetimibe, an NPCL inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis. Free Radic Biol Med. 20 Sep 2;:520-52.
[]. Yijun Zhu, et al. Efficient and scalable process for the synthesis of antihypercholesterolemic drug ezetimibe. Synthetic Communications. 20, 4:20, 87-.
H02-H-H72-H40
P20-P24-P270-P27-P280-P0-P-P50
077